Numerous concerns have been raised about excess mortality persisting beyond the COVID-19 pandemic. COVID-19 and the lockdowns are typically offered as explanantia, with some suggesting that COVID-19 vaccines could be contributing. With its relative isolation it is prudent to pay attention to Australia, which provides a unique opportunity to consider what effectively became a large-scale vaccine safety trial.
Objective
The purpose of this study is to determine the plausibility of COVID-19 vaccination contributing to Australia’s excess mortality.
Methods
Various regions of Australia displaying excess mortality were identified, and then the plausibility of three explanantia were considered in turn: COVID-19, the lockdowns, and COVID-19 vaccines.
Findings
I found that in 4 of Australia’s 8 major regions excess mortality was present, correlating with rapid and thorough COVID-19 vaccination programs, before mass exposure to COVID-19, and in the absence of lengthy and highly restrictive lockdowns.
Conclusions
Combined with increasing evidence that the efficacy/effectiveness and safety of COVID-19 vaccines have been greatly exaggerated, including acknowledgements from the Australian and American governments that several deaths have been caused by the vaccines, these findings make it a near-certainty that COVID-19 vaccines have been – and continue to be – contributing to excess mortality.
Pearson-StuttardJCaulSMcDonaldS, et al.Excess mortality in England post COVID-19 pandemic: implications for secondary prevention. The Lancet Regional Health - Europe2024; 36: 100802. https://doi.org/10.1016/j.lanepe.2023.100802
2.
KuhbandnerCReitznerM. Estimation of excess mortality in Germany during 2020-2022. Cureus2023; 15(5): e39371. https://doi.org/10.7759/cureus.39371
BlayJYSBLe VuB, et al.Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France. ESMO Open2021; 6(3): 100134. https://doi.org/10.1016/j.esmoop.2021.100134
6.
MostertSHooglandMHuibersM, et al.Excess mortality across countries in the Western world since the COVID-19 pandemic: ‘our World in Data’ estimates of January 2020 to December 2022. BMJ Public Health2024; 2(1): e000282. https://doi.org/10.1136/bmjph-2023-000282
7.
AarstadJKvitasteinOA. Is there a link between the 2021 COVID-19 vaccination uptake in Europe and 2022 excess all-cause mortality?Asian Pacific Journal of Health Sciences2023; 10(1): 25–31. https://doi.org/10.21276/apjhs.2023.10.1.6
AllenDE. The correlation between Australian excess deaths by state and booster vaccinations. Medical Research Archives2024; 12(7). https://doi.org/10.18103/mra.v12i7.5485
10.
KuhbandnerCReitznerM. Regional patterns of excess mortality in Germany during the COVID-19 pandemic: a state-level analysis. R Soc Open Sci2025; 12(11): 250790. https://doi.org/10.1098/rsos.250790
11.
OkoroEOIkobaNAOkoroBE, et al.Paradoxical increase in global COVID-19 deaths with vaccination coverage: World health organization estimates (2020–2023). Int J Risk Saf Med2025; 36(3): 103–112. https://doi.org/10.1177/09246479251336610
12.
KakeyaHNittaTKamijimaY, et al.Significant increase in excess deaths after repeated COVID-19 vaccination in Japan. JMA Journal2025; 8(2): 584–586. https://doi.org/10.31662/jmaj.2024-0298
GohAMYDangCWijesuriyaR, et al.The impact of strict lockdowns on the mental health and well-being of people living in Australia during the first year of the COVID-19 pandemic. BJPsych Open2023; 9(3): e90. https://doi.org/10.1192/bjo.2023.65
BasoulisDLogiotiKPapaodysseaI, et al.Deaths “due to” COVID-19 and deaths “with” COVID-19 during the omicron variant surge, among hospitalized patients in seven tertiary-care hospitals, Athens, Greece. Sci Rep2025; 15: 13728. https://doi.org/10.1038/s41598-025-98834-y
ChoJYKimKHLeeN, et al.COVID-19 vaccination-related myocarditis: a Korean nationwide study. Eur Heart J2023; 44: 2234–2243. https://doi.org/10.1093/eurheartj/ehad339
RamadanMSoeskov DavidovskiFEspersenC, et al.Long term cardiac function and symptoms in patients following COVID-19 vaccination myocarditis. Eur Heart J2025; 46: 2583. https://doi.org/10.1093/eurheartj/ehaf784.2583
MongeSPastor-BarriusoRHernánMA. The imprinting effect of covid-19 vaccines: an expected selection bias in observational studies. Br Med J2023; 381: e074404. https://doi.org/10.1136/bmj-2022-074404
AmerSAAl-ZahraniAImamEA, et al.Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study. Sci Rep2024; 14: 4785. https://doi.org/10.1038/s41598-024-54886-0
56.
LanggartnerDWinklerRBrunner-WeiserJ, et al.COVID-19 vaccination exacerbates ex vivo IL-6 release from isolated PBMCs. Sci Rep2023; 13: 9496. https://doi.org/10.1038/s41598-023-35731-2
LiuBStepienSDobbinsT, et al.Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study. Lancet Reg Health West Pac2023; 40: 100928. https://doi.org/10.1016/j.lanwpc.2023.100928
59.
Rubio-CasillasACowleyDRaszekM, et al.Review: N1-Methyl-Pseudouridine (m1Ψ): friend or foe of cancer?Int J Biol Macromol2024; 267(1): 131427. https://doi.org/10.1016/j.ijbiomac.2024.131427
60.
SpeicherDJRoseJMcKernanK. Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and moderna modRNA COVID-19 vaccines from Ontario, Canada. Autoimmunity2025; 58(1): 2551517. https://doi.org/10.1080/08916934.2025.2551517
KimHKimMHChoiM, et al.1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea. Biomark Res2025; 13(114): 114. https://doi.org/10.1186/s40364-025-00831-w
63.
SanoS. A case of metastatic breast carcinoma to the skin expressing SARS-CoV-2 spike protein possibly derived from mRNA vaccine. J Dermatol Sci2025; 120(2): 71–73. https://doi.org/10.1016/j.jdermsci.2025.09.007
64.
FungKJonesMDoshiP. Sources of bias in observational studies of covid-19 vaccine effectiveness. J Eval Clin Pract2024; 30(1): 30–36. https://doi.org/10.1111/jep.13839
65.
LatasterR. Reply to Fung LR, et al. On COVID-19 vaccine case-counting window biases overstating vaccine effectiveness. J Eval Clin Pract2024; 30(1): 82–85. https://doi.org/10.1111/jep.13892
66.
DoshiPFungK. How the case counting window affected vaccine efficacy calculations in randomized trials of COVID-19 vaccines. J Eval Clin Pract2024; 30(1): 105–106. https://doi.org/10.1111/jep.13900
67.
LatasterR. How the adverse effect counting window affected vaccine safety calculations in randomised trials of COVID-19 vaccines. J Eval Clin Pract2024; 30(3): 453–458. https://doi.org/10.1111/jep.13962
BennCSSchaltz-BuchholzerFNielsenS, et al.Randomised clinical trials of COVID-19 vaccines: do adenovirus-vector vaccines have beneficial non-specific effects?iScience2023; 26(5): 106733. https://doi.org/10.1016/j.isci.2023.106733
70.
FaksovaKWalshDJiangY, et al.COVID-19 vaccines and adverse events of special interest: a multinational global vaccine data network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine2024; 42(9): 2200–2211. https://doi.org/10.1016/j.vaccine.2024.01.100
71.
RaethkeMvan HunselFLuxiN, et al.Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study. Vaccine2024; 42(9): 2357–2369. https://doi.org/10.1016/j.vaccine.2024.03.001
72.
GrabowskiJNiebrzydowskaABrzozowskaA, et al.Underreporting of adverse events following COVID-19 vaccination among healthcare professionals in Poland: potential implications for vaccine hesitancy. Trop Med Infect Dis2025; 10(11): 320. https://doi.org/10.3390/tropicalmed10110320
73.
LatasterR. Metacritique of Influential Studies Purporting COVID-19 Vaccine Successes: part 1 - Watson et al. Journal of Independent Medicine2025; 1(2): 143–152. https://doi.org/10.71189/JIM/2025/V01N02A07
JohnsonR. The corruption of science and federal health agencies: how health officials downplayed and hid myocarditis and other adverse events associated with the COVID-19 vaccines. https://x.com/i/broadcasts/1yoKMopkrQRJQ (2025, Accessed 25 May 2025).
76.
IoannidisJPAPezzulloAMCristianoA, et al.Global estimates of lives and life-years saved by COVID-19 vaccination during 2020-2024. JAMA Health Forum2025; 6(7): e252223. https://doi.org/10.1001/jamahealthforum.2025.2223
GeorgievSBorissovBVodenicharovaA, et al.The dual economic impact of COVID-19 vaccine hesitancy - bulgaria’s conundrum case. Pharmacia2025; 72: 1–4. https://doi.org/10.3897/pharmacia.72.e173509
84.
FürstTBazalováAFryčákT, et al.Does the healthy vaccinee bias rule them all? Association of COVID-19 vaccination status and all-cause mortality from an analysis of data from 2.2 million individual health records. Int J Infect Dis2024; 142: 106976. https://doi.org/10.1016/j.ijid.2024.02.019
